(-)-Tylophorine
(-)-Tylophorine ((-)-(R)-Tylophorine) is a potent cytotoxic agent with activity against both drug-sensitive and multidrug-resistant cancer cell lines. (-)-Tylophorine has been explored in biomedical research for its anticancer applications.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 111408-21-0
- Formule: C24H27NO4
- Masse moléculaire:393.48
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
Description
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| A549 | GI50 |
0.5 μM
Compound: 3
|
Antiproliferative activity against human A549 cells after 72 hrs by MTT assay
Antiproliferative activity against human A549 cells after 72 hrs by MTT assay
|
[PMID: 22417638] |
| CCRF-CEM | GI50 |
67 nM
Compound: (-)-R-tylophorine
|
Growth inhibition of human CEM cells
Growth inhibition of human CEM cells
|
[PMID: 18077159] |
| HeLa | IC50 |
3.1 μM
Compound: 5
|
Cytotoxicity against human HeLa cells after 48 hrs by WST8 colorimetric assay
Cytotoxicity against human HeLa cells after 48 hrs by WST8 colorimetric assay
|
[PMID: 19938815] |
| HL-60 | GI50 |
0.1 μM
Compound: 3
|
Antiproliferative activity against human HL60 cells after 72 hrs by SRB assay
Antiproliferative activity against human HL60 cells after 72 hrs by SRB assay
|
[PMID: 22417638] |
| HONE1 cell line | GI50 |
0.27 μM
Compound: 9a
|
Growth inhibition of human HONE1 cells
Growth inhibition of human HONE1 cells
|
[PMID: 23167614] |
| Huh-7 | CC50 |
>7.91 μM
Compound: GNF-Pf-838
|
NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)
NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)
|
[PMID: 18579783] |
| KB 3-1 | IC50 |
214 nM
Compound: 5
|
Cytotoxicity against drug-resistant human KB-3-1 cells by MTS/PMS assay
Cytotoxicity against drug-resistant human KB-3-1 cells by MTS/PMS assay
|
[PMID: 12350151] |
| KB-V1 | IC50 |
173 nM
Compound: 5
|
Cytotoxicity against multidrug-resistant human KBV1 cells by MTS/PMS assay
Cytotoxicity against multidrug-resistant human KBV1 cells by MTS/PMS assay
|
[PMID: 12350151] |
| MCF7 | GI50 |
0.032 μM
Compound: (R)-tylophorine
|
Growth inhibition in human MCF7 cells after 72 hrs by alamar blue assay
Growth inhibition in human MCF7 cells after 72 hrs by alamar blue assay
|
[PMID: 22910225] |
| MCF7 | GI50 |
0.24 μM
Compound: 9a
|
Growth inhibition of human MCF7 cells
Growth inhibition of human MCF7 cells
|
[PMID: 23167614] |
| NCI-H460 | GI50 |
0.23 μM
Compound: 9a
|
Growth inhibition of human NCI-H460 cells
Growth inhibition of human NCI-H460 cells
|
[PMID: 23167614] |
| NUGC-3 | GI50 |
0.19 μM
Compound: 9a
|
Growth inhibition of human NUGC3 cells
Growth inhibition of human NUGC3 cells
|
[PMID: 23167614] |
| PANC-1 | GI50 |
29 nM
Compound: (-)-R-tylophorine
|
Growth inhibition of human PANC1 cells
Growth inhibition of human PANC1 cells
|
[PMID: 18077159] |
| RAW264.7 | CC50 |
1.24 μM
Compound: 9a
|
Cytotoxicity against mouse RAW264.7 cells
Cytotoxicity against mouse RAW264.7 cells
|
[PMID: 23167614] |
| RAW264.7 | EC50 |
0.27 μM
Compound: 9a
|
Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced nitric oxide production incubated for 18 hrs by nitrate/nitrite assay
Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced nitric oxide production incubated for 18 hrs by nitrate/nitrite assay
|
[PMID: 23167614] |
| RAW264.7 | IC50 |
430 nM
Compound: 3
|
Antiinflammatory activity against mouse RAW264.7 cells assessed as inhibition of LPS-induced TNFalpha production after 6 hrs by ELISA
Antiinflammatory activity against mouse RAW264.7 cells assessed as inhibition of LPS-induced TNFalpha production after 6 hrs by ELISA
|
[PMID: 25221661] |
| RAW264.7 | IC50 |
823 nM
Compound: 3
|
Cytotoxicity against mouse RAW264.7 cells after 48 hrs by MTT assay
Cytotoxicity against mouse RAW264.7 cells after 48 hrs by MTT assay
|
[PMID: 25221661] |
| SF-268 | GI50 |
0.27 μM
Compound: 9a
|
Growth inhibition of human SF268 cells
Growth inhibition of human SF268 cells
|
[PMID: 23167614] |
| Splenocyte | IC50 |
1215 nM
Compound: 3
|
Antiinflammatory activity against BALB/c mouse splenocytes assessed as inhibition of LPS-induced TNFalpha production after 24 hrs by ELISA
Antiinflammatory activity against BALB/c mouse splenocytes assessed as inhibition of LPS-induced TNFalpha production after 24 hrs by ELISA
|
[PMID: 25221661] |
| Splenocyte | IC50 |
208 nM
Compound: 3
|
Antiinflammatory activity against BALB/c mouse splenocytes assessed as inhibition of LPS-induced TNFalpha production after 4 hrs by ELISA
Antiinflammatory activity against BALB/c mouse splenocytes assessed as inhibition of LPS-induced TNFalpha production after 4 hrs by ELISA
|
[PMID: 25221661] |
Chemical Information
-
CAS No. 111408-21-0
-
Masse moléculaire 393.48
-
Formule C24H27NO4
-
SMILES
COC1=C(OC)C=C2C3=CC(OC)=C(OC)C=C3C4=C(CN5[C@@](CCC5)([H])C4)C2=C1
-
Synonyms
(-)-(R)-Tylophorine; (-)-DCB-3500; (-)-NSC-717335
-
Structure Classification
-
Initial Source
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocole
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)